VENTANA CLDN18 (43-14A) RxDx Assay
Product TypeAssay Kit
TechnologyIHC Staining
Catalog / REF760-700

Key takeaways
VENTANA CLDN18 (43-14A) RxDx Assay is a product in the Histology & IHC category, manufactured by Roche Diagnostics.
- Platform: IHC Staining
Classification
- Category
- Histology & IHC
- Product Type
- Assay Kit
- Technology
- IHC Staining
From the manufacturer
Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.
The FDA-approved VENTANA CLDN18 (43-14A) RxDx Assay measures expression of both variants of the CLDN18 protein; however, CLDN18.2 is the dominant variant expressed in gastric cancers, making it the only candidate for identifying a previously undefined subset of patients.
CLDN18.2 expression was assessed by IHC using the investigational VENTANA CLDN18 (43-14A) RxDx Assay in the SPOTLIGHT and GLOW clinical trials.
Review and references
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-16
2026-11-01
availability varies
